[RET is the most important target for recent systemic therapy trials of MTC, along with vascular endothelial growth factor receptors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
Gene-disease associations inferred from text-mining the literature.
DisGeNET evidence - LITERATURE